Literature DB >> 11149659

Hydroxychloroquine-induced seizure in a patient with systemic lupus erythematosus.

G Malcangi1, P Fraticelli, C Palmieri, M Cappelli, M G Danieli.   

Abstract

We report on a case of a 17-year-old female with systemic lupus erythematosus (SLE), with a clinical history of complex partial seizure, who developed a tonicoclonic crisis after receiving hydroxychloroquine for 2 weeks at a dosage of 200 mg/day (5 mg/kg). The absence of previous similar episodes and of recurrences after withdrawal of the drug in subsequent months, the short latency after administration and the favourable short-term evolution raised suspicions for a potential role of the drug in the development of the isolated convulsive crisis. It is possible for hydroxychloroquine to be responsible for tonicoclonic seizures in predisposed subjects.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11149659     DOI: 10.1007/s002960000066

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  8 in total

1.  Seizure associated with chloroquine therapy in a patient with systemic lupus erythematosus.

Authors:  Antonio G Tristano; Luz Falcón; María Willson; Ivette Montes de Oca
Journal:  Rheumatol Int       Date:  2004-01-23       Impact factor: 2.631

2.  Keeping people with epilepsy safe during the COVID-19 pandemic.

Authors:  Jacqueline A French; Martin J Brodie; Roberto Caraballo; Orrin Devinsky; Ding Ding; Lara Jehi; Nathalie Jette; Andres Kanner; Avani C Modi; Charles R Newton; Archana A Patel; Page B Pennell; Emilio Perucca; Josemir W Sander; Ingrid E Scheffer; Gagandeep Singh; Emma Williams; Jo Wilmshurst; J Helen Cross
Journal:  Neurology       Date:  2020-04-23       Impact factor: 9.910

3.  Differential diagnosis of high serum creatine kinase levels in systemic lupus erythematosus.

Authors:  Jutta G Richter; Arnd Becker; Benedikt Ostendorf; Christof Specker; G Stoll; E Neuen-Jacob; Matthias Schneider
Journal:  Rheumatol Int       Date:  2003-05-09       Impact factor: 2.631

Review 4.  Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.

Authors:  Anwar M Hashem; Badrah S Alghamdi; Abdullah A Algaissi; Fahad S Alshehri; Abdullah Bukhari; Mohamed A Alfaleh; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2020-05-06       Impact factor: 6.211

Review 5.  Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).

Authors:  Catherine Wei Min Ong; Giovanni Battista Migliori; Mario Raviglione; Gavin MacGregor-Skinner; Giovanni Sotgiu; Jan-Willem Alffenaar; Simon Tiberi; Cornelia Adlhoch; Tonino Alonzi; Sophia Archuleta; Sergio Brusin; Emmanuelle Cambau; Maria Rosaria Capobianchi; Concetta Castilletti; Rosella Centis; Daniela M Cirillo; Lia D'Ambrosio; Giovanni Delogu; Susanna M R Esposito; Jose Figueroa; Jon S Friedland; Benjamin Choon Heng Ho; Giuseppe Ippolito; Mateja Jankovic; Hannah Yejin Kim; Senia Rosales Klintz; Csaba Ködmön; Eleonora Lalle; Yee Sin Leo; Chi-Chiu Leung; Anne-Grete Märtson; Mario Giovanni Melazzini; Saeid Najafi Fard; Pasi Penttinen; Linda Petrone; Elisa Petruccioli; Emanuele Pontali; Laura Saderi; Miguel Santin; Antonio Spanevello; Reinout van Crevel; Marieke J van der Werf; Dina Visca; Miguel Viveiros; Jean-Pierre Zellweger; Alimuddin Zumla; Delia Goletti
Journal:  Eur Respir J       Date:  2020-10-01       Impact factor: 16.671

Review 6.  Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19.

Authors:  George G Zhanel; Michael A Zhanel; Kevin F Boreskie; Joseph P Lynch; James A Karlowsky
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-09-15       Impact factor: 2.471

7.  Seizures as a rare adverse effect of chloroquine therapy in systemic lupus erythematosus patients: a case report and literature survey.

Authors:  Piotr Krzeminski; Aleksandra Lesiak; Joanna Narbutt
Journal:  Postepy Dermatol Alergol       Date:  2018-08-21       Impact factor: 1.837

8.  Fahr's syndrome presenting with seizures in SARS-CoV-2 (COVID-19) pneumonia-a case report.

Authors:  Gürkan Demir; Onur Balaban; Muhammet Halit Tekeci; Zeynep Issı; Ali Fuat Erdem
Journal:  Neurol Sci       Date:  2020-09-23       Impact factor: 3.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.